Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Linz, Upper Austria, 4020, Austria
NCT Number: NCT05779306
To evaluate and compare the post-operative outcome of two different sceral fixated IOL concepts, the Yamane method (ZA9003, J&J, USA) and the Carlevale IOL (FIL-SSF, Soleko, Italy).
Looking for future studies?
Notify Me21 year–110 year
All sexes
Observational
Linz, Upper Austria, 4020, Austria
Various approaches to fix the haptics in the sclera can be found in literature. A distinction can be made between suture-fixed and sutureless techniques. The former often proves to be technically challenging and complicated, which has led to an increased rethinking towards sutureless implantation in recent years.
The popular Yamane technique or "flanged IOL fixation" uses a double-needle technique that creates a scleral tunnel and fixates the haptics seamlessly using two 30-gauge needles. However, the haptics must be bent for this purpose Thus, this method is not ideal, since besides from the high degree of manipulation necessary for implantation of the IOL, it is also prone to dislocation and tilt.
A more recent approach is the Carlevale FIL-SSF IOL (Soleko, Italy), which was developed specifically for use in aphakia with a lack of capsular stability. Using two t-shaped anchors, the lens is positioned in two scleral flaps at 180 degrees to each other, without the preparation of a tunnel or excessive manipulation of the haptics. These two self-blocking anchors also provide a great deal of stability. The extent of abberations is also much less with this type of lens implantation, as the fixed position reduces the risk of them. Thus, the Carlevale technique represents a new, potentially superior option for intrascleral fixation.
However, all these types of implantation are not free from aberrations, tilt, or even dislocation. Many factors influence the outcome of IOL implantation, the optimal choice of intraocular lens power, the surgeon's experience regarding fixation in more challenging eyes, or individual anatomical conditions. As part of quality management, an evaluation of monthly and six-monthly data will be performed. The aim of this study is the evaluation of the postoperative tilt of the Carlevale lens, as well as the evaluation of the corrected and uncorrected visual acuity and the anterior chamber depth within the clinical quality management. Patients who have already undergone surgery are called to our clinic by telephone at the earliest 6 weeks after surgery for a one-time follow-up appointment.
The collected data is then evaluated and analyzed as well as compared to the Yamane data.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Biometry using the IOL Master 700
Anterior segment-OCT to evaluate lens tilt
Corneal Topography using the MS-39
Abberometry using the OSIRIS-Abberometer
Evaluation of Refraction using an Autorefractor
Refraction performed by experienced staff
Time frame: 6 Weeks
Postoperative Tilt
Time frame: 6 Weeks
Refraction using an automated refractor
Time frame: 6 Weeks
Refraction performed by experienced staff
Time frame: 6 Weeks
Measurement performed by experienced staff
Time frame: 6 Weeks
Measurement performed by experienced staff
Johannes Kepler University of Linz
Other
Acronym: Carlevale
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06201455
Capsule Opacification, Cataract
Guangzhou, Guangdong, China
View Trial DetailsNCT07729189
Capsule Opacification, Cataract
Multan, Punjab Province, Pakistan
View Trial DetailsNCT05213390
After Cataract, Capsule Opacification
London, United Kingdom
View Trial DetailsNCT01732484
Capsule Opacification, Cataract
View Trial Details